Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMID 16943176)

Published in Am J Geriatr Psychiatry on September 01, 2006

Authors

Ellyn M Johnson1, Ellen Whyte, Benoit H Mulsant, Bruce G Pollock, Elizabeth Weber, Amy E Begley, Charles F Reynolds

Author Affiliations

1: Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Articles citing this

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40

Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol (2007) 1.27

Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J Clin Psychiatry (2014) 1.08

Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One (2014) 1.08

Position paper on the importance of psychosocial factors in cardiology: Update 2013. Ger Med Sci (2014) 0.89

Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc (2010) 0.84

Introduction: chronic medical conditions and depression--the view from primary care. Am J Med (2008) 0.82

Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups. Eur J Clin Pharmacol (2014) 0.78

Depression care management for late-life depression in China primary care: protocol for a randomized controlled trial. Trials (2011) 0.77

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry (2007) 0.76

Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residents. CMAJ (2011) 0.75

Current challenges and pitfalls in the pharmacological treatment of depression. J Med Life (2015) 0.75

Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. J Clin Psychopharmacol (2016) 0.75

Venlafaxine-induced orthostatic hypotension in a geriatric patient. Case Rep Psychiatry (2013) 0.75

Articles by these authors

Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA (2004) 8.83

Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61

Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15

Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81

Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med (2003) 4.30

Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA (2009) 4.06

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry (2004) 3.84

Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med (2011) 3.73

Recruiting and retaining future generations of physician scientists in mental health. Arch Gen Psychiatry (2002) 3.69

Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med (2006) 3.27

The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17

Confronting depression and suicide in physicians: a consensus statement. JAMA (2003) 3.06

The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06

Preventing depression: a global priority. JAMA (2012) 2.92

Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56

The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol (2006) 2.40

Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med (2009) 2.40

Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30

Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23

Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med (2006) 2.22

The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study. J Am Geriatr Soc (2005) 2.20

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res (2003) 2.14

A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res (2006) 2.08

Depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc (2014) 2.08

Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry (2009) 2.08

A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry (2007) 2.04

Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry (2005) 2.04

Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ (2013) 1.91

Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol (2014) 1.85

Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc (2007) 1.85

Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77

Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study. Neurobiol Aging (2010) 1.77

Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry (2002) 1.76

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry (2005) 1.76

The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med (2006) 1.75

Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75

Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry (2002) 1.70

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry (2003) 1.70

Effect of rehabilitation site on functional recovery after hip fracture. Arch Phys Med Rehabil (2005) 1.69

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry (2007) 1.68

Mental health treatment seeking among older adults with depression: the impact of stigma and race. Am J Geriatr Psychiatry (2010) 1.67

Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry (2007) 1.67

Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry (2008) 1.66

A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry (2005) 1.65

Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc (2014) 1.65

Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62

Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry (2012) 1.62

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry (2008) 1.62

Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry (2003) 1.60

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60

The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry (2007) 1.59

Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry (2004) 1.59

Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet (2004) 1.57

Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry (2002) 1.57

Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54

Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan. Psychiatry Clin Neurosci (2009) 1.54

Programs for developing the pipeline of early-career geriatric mental health researchers: outcomes and implications for other fields. Acad Med (2010) 1.52

Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis. Stroke (2007) 1.52

Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry (2004) 1.51

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry (2013) 1.51

Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain (2002) 1.50

Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50

Bereavement, complicated grief, and DSM, part 1: depression. J Clin Psychiatry (2010) 1.49